SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-244267
Filing Date
2017-08-01
Accepted
2017-08-01 16:16:01
Documents
3
Period of Report
2017-08-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d424945d8k.htm 8-K 17108
2 EX-99.1 d424945dex991.htm EX-99.1 41632
3 GRAPHIC g424945g0729031640429.jpg GRAPHIC 2596
  Complete submission text file 0001193125-17-244267.txt   63586
Mailing Address 10614 SCIENCE CENTER DRIVE SAN DIEGO CA 92121
Business Address 10614 SCIENCE CENTER DRIVE SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35670 | Film No.: 17996917
SIC: 2834 Pharmaceutical Preparations